Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Hesketh, Paul
One or more keywords matched the following items that are connected to Hesketh, Paul
Item TypeName
Concept Neurokinin-1 Receptor Antagonists
Academic Article Chemotherapy-induced nausea and vomiting.
Academic Article Acute emesis: moderately emetogenic chemotherapy.
Academic Article Consensus recommendations for the prevention of vomiting and nausea following high-emetic-risk chemotherapy.
Academic Article Understanding the pathobiology of chemotherapy-induced nausea and vomiting. Providing a basis for therapeutic progress.
Academic Article 2023 updated MASCC/ESMO Consensus recommendations: Prevention of nausea and vomiting following moderately emetic risk antineoplastic agents.
Academic Article Defining the efficacy of neurokinin-1 receptor antagonists in controlling chemotherapy-induced nausea and vomiting in different emetogenic settings-a meta-analysis.
Academic Article Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program.
Academic Article Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis.
Academic Article Evaluation of new antiemetic agents and definition of antineoplastic agent emetogenicity--state of the art.
Academic Article Reduction of cisplatin-induced emesis by a selective neurokinin-1-receptor antagonist. L-754,030 Antiemetic Trials Group.
Academic Article Use of an NK1 receptor antagonist to prevent delayed emesis after cisplatin.
Academic Article Antiemetics: American Society of Clinical Oncology clinical practice guideline update.
Academic Article Consensus proposals for the prevention of acute and delayed vomiting and nausea following high-emetic-risk chemotherapy.
Academic Article The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.
Academic Article Differential involvement of neurotransmitters through the time course of cisplatin-induced emesis as revealed by therapy with specific receptor antagonists.
Academic Article Differential time course of action of 5-HT3 and NK1 receptor antagonists when used with highly and moderately emetogenic chemotherapy (HEC and MEC).
Academic Article Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
Academic Article Efficacy of the neurokinin-1 receptor antagonist rolapitant in preventing nausea and vomiting in patients receiving carboplatin-based chemotherapy.
Search Criteria
  • Neurokinin 1 Receptor Antagonists